Situationmaterial
FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type ...
Carried more widely than almost anything else in the last 30 days
◆ Sectors
Health
◆ Where
United States
◆ Timeline
- 28 August 2026FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type ...investor.lilly.com
- 29 August 2026Lilly joins Novo in cardiovascular space after FDA nod for GLP-1/GIP agonist Mounjarobiospace.com
- 30 August 2026Mounjaro Approved for Heart Attack, Stroke Risk Reduction in Diabeteschosun.com
- 31 August 2026Eli Lilly gets green light to market Mounjaro for heart attacks and strokes in the USmedwatch.com
- 1 September 2026Does Mounjaro Reduce the Risk of Heart Attack + Stroke with Type 2 Diabetes? The FDA Says Yesbeyondtype1.org
◆ Connected developments
Situations Wire finds semantically close to this one. Proximity, not cause.
◆ Share
◆ Wire has not analysed this situation yet
Below is every report Wire has gathered on this event, and the situations it connects to. The deeper analysis — why it happened, what changed, what would prove it wrong — is not written yet, so nothing here claims it.
◆ Evidence
18 reports · 17 domains